CPRT vs MREO · P/E 19, rev $3.51B vs $48.7M cap
Copart Inc (CPRT) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. MREO currently screens at market cap $48.7M.
Not investment advice. Open the CPRT and MREO stock pages for the full models.
Not investment advice.